Skip to content

Attempt to quantify acute pain using Pain Vision TM

Quantitative evaluation of experimental acute pain using Pain Vision TM - Evaluation of acute pain using Pain Vision TM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047894
Enrollment
18
Registered
2022-06-01
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pain

Interventions

Capsaicin: 1% capsaicin 0.1 ml, subcutaneously administered Mustard oil: 1 x 1 cm, applied for 5 minutes Needle puncture: Disposable needle puncture 5 mm perpendicular to the skin

Sponsors

Shinshu university school of medicine, Department of Anesthesiology and Resuscitology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Healthy adults who are 20 years of age or older at the time of consent acquisition 2.Persons who have obtained written consent based on the free will of the subject after receiving sufficient explanation for participation in this study.

Exclusion criteria

Exclusion criteria: 1.Those who have previously been allergic to capsaicin (chili pepper) and mustard oil (mustard) and those who are afraid of needles (aichmophobia) 2.Patients with a history of central nervous system disorder, heart disease, respiratory disease, or renal disease 3.Those who are taking painkillers 4.Pregnant or lactating female patients 5.Persons who the principal investigator deems inappropriate as a subject

Design outcomes

Primary

MeasureTime frame
Correlation between pain degree using PainVisionTM and visual analogue scale (VAS) or numerical rating scale (NRS)

Countries

Japan

Contacts

Public ContactYuki Yoshiyama

Shinshu university school of medicine Department of Anesthesiology and Resuscitology

yoshiyama@shinshu-u.ac.jp0263-37-2670

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026